※ Click on the participating company name below to see more information by company.
| Zone |
Company Name |
Exhibit Item |
Booth no. |
|
PARTNERING
|
MolGenBio Co., Ltd.
|
MolGenBio is developing a novel proprietary synthetic biology platform technology targeting intractable diseases such as neurodegenerative diseases and cancer. Our innovative and robust platform technology aims to develop the first/best-in-class small molecule therapeutics by harnessing the expertise in microbial genome scanning, editing and assembly. Our proprietary MTG (Molecule Through Gene) platform enables us to generate structural derivatives of small molecule drug candidates that are difficult to synthesize through the conventional medicinal chemistry approach. Our CEO/founder Prof Yoon at Seoul National University elucidated the complete biosynthetic pathway of FK506 for the first time. MolGenBio team has world-class expertise in tacrolimus R&D/manufacturing.
|
E41
|
|
KOREA LIFE SCIENCE
|
MS Automation
|
Imaging Module
|
C56
|
|
KOREA LIFE SCIENCE
|
MyMedics Co.,Ltd.
|
Auto-Cpap, Oxygen Concentrator, Cpap Supplies.
|
E46
|
KYUNGYON EXHIBITION CORP.